Difference between revisions of "Talk:Bioblast 2022"
From Bioblast
Line 5: | Line 5: | ||
! Time (CET) !!Topic !! Time per lecture !!Title !! Speaker | ! Time (CET) !!Topic !! Time per lecture !!Title !! Speaker | ||
|- | |- | ||
| '''09:15 | | '''09:15''' || || || 1.1 - ''Opening speech'' [[Bioblasts |Bioblasts - the taxonomic unit of bioenergetics: mitochondria, chloroplasts, aerobic bacteria''']] || [[Gnaiger Erich]] | ||
|- | |- | ||
|- | |- | ||
| '''09:45 | | '''09:45''' || '''Scientific Session I''' || || '''Evolutionary perspectives of bioenergetics + Algal bioenergetics''' || | ||
|- | |- | ||
|- | |- | ||
Line 14: | Line 14: | ||
|- | |- | ||
|- | |- | ||
| || || 10:15 || || | | || || 10:15 || [[Donnelly 2022 Abstract Bioblast|The ABC of hypoxia – what is the norm?]] || [[Donnelly Chris]] | ||
|- | |- | ||
|- | |- | ||
Line 20: | Line 20: | ||
|- | |- | ||
|- | |- | ||
| || || 11:00 || [[ | | || || 11:00 || [[Vera Vives 2022 MitoFit |The robustness of NextGen-O2k for building PI curves in microalgae ]] || [[Morosinotto Tomas]] | ||
|- | |- | ||
|- | |- | ||
Line 29: | Line 29: | ||
|- | |- | ||
|- | |- | ||
| || || 11:30 | | || || 11:30|| [[Komlodi 2022 MitoFit |The protonmotive force - not merely membrane potential || [[Komlodi Timea]] | ||
|- | |- | ||
|- | |- | ||
| || || 11:45 | | || || 11:45 || [[Alencar 2022 MitoFit |A unifying hypothesis for the extraordinary energy metabolism of bloodstream Trypanosoma brucei]] || [[Oliveira Marcus F]] | ||
|- | |- | ||
|- | |- | ||
| || || 12:00 | | || || 12:00 ||[[Chicco Adam J |Resolving the Rotenone Paradox: elucidating the Complexity of multi-substrate respirometry protocols]] || [[Chicco Adam J]] | ||
|- | |- | ||
|- | |- | ||
Line 41: | Line 41: | ||
|- | |- | ||
|- | |- | ||
| || || 12:15 | | || || 12:15 || || | ||
|- | |- | ||
|- | |- | ||
| || || 12:20 | | || || 12:20 || || | ||
|- | |- | ||
|- | |- | ||
| || || 12:20 | | || || 12:20 || | | ||
|- | |- | ||
|- | |- | ||
Line 56: | Line 56: | ||
|- | |- | ||
|- | |- | ||
| || || 14:00 | | || || 14:00|| || | ||
|- | |- | ||
|- | |- | ||
| || || 14:15 | | || || 14:15 || [[MX Mexiko City Moreno-Sanchez R |Estimation of energy pathway fluxes in cancer cells- beyond the Warburg effect]] || [[MX Mexiko City Moreno-Sanchez R]] | ||
|- | |- | ||
|- | |- | ||
| || || 14:30 | | || || 14:30 || || | ||
|- | |- | ||
|- | |- | ||
| || || 14:45 | | || || 14:45 || ::::## [[Neuzil Jiri|Metabolic switch utilizing ammonia supports proliferation in regenerating liver]] || [[Neuzil Jiri]] | ||
|- | |- | ||
|- | |- | ||
Line 71: | Line 71: | ||
|- | |- | ||
|- | |- | ||
| || || 15:00 | | || || 15:00 || || | ||
|- | |- | ||
|- | |- | ||
| || || 15:05 | | || || 15:05 || || | ||
|- | |- | ||
|- | |- | ||
| || || 15:10 | | || || 15:10|| || | ||
|- | |- | ||
|- | |- | ||
| || || 15:15 | | || || 15:15 || || | ||
|- | |- | ||
|- | |- | ||
| || || 15:20 | | || || 15:20 || || | ||
|- | |- | ||
|- | |- | ||
| || || 15:25 | | || || 15:25 || || | ||
|- | |- | ||
|- | |- | ||
Line 95: | Line 95: | ||
|- | |- | ||
|- | |- | ||
| || || 16:00 | | || || 16:00|| [[Stiban Johnny|NUBPL: a mitochondrial Complex I deficiency disorder]] || [[Stiban Johnny]] | ||
|- | |- | ||
|- | |- | ||
| || || 16:15 | | || || 16:15|| [[Chakrabarti Sasanka |Rotenone cytotoxicity on SH-SY5Y cells: role of ferroptosis, mitochondria and alpha-synuclein]] || [[Chakrabarti Sasanka]] | ||
|- | |- | ||
|- | |- | ||
| || || 16:30 | | || || 16:30|| || | ||
|- | |- | ||
|- | |- | ||
| || || 16:35 | | || || 16:35|| || | ||
|- | |- | ||
|- | |- | ||
| || || 16:40 | | || || 16:40|| || | ||
|- | |- | ||
|- | |- | ||
| || || 16:45 | | || || 16:45|| || | ||
|- | |- | ||
|- | |- | ||
| || || 17:00 | | || || 17:00|| [[Karabatsiakis Alexander |Effects of eye-movement desensitization and reprocessing (EMDR) therapy on mitochondrial bioenergetics in immune cells from patients with post-traumatic stress disorder (PTSD): a pilot study]] || [[Karabatsiakis Alexander]] | ||
|- | |- | ||
|- | |- |
Revision as of 08:13, 18 May 2022
Program
2022-06-29 Day 1 of scientific presentations
2022-06-30 Day 2 of scientific presentations